# Assessment of the Human Systemic Absorption of Sunscreen Ingredients

> **NCT03582215** · PHASE1 · COMPLETED · sponsor: **Food and Drug Administration (FDA)** · enrollment: 72 (actual)

## Conditions studied

- Systemic Exposure to Sunscreen Ingredients

## Interventions

- **DRUG:** Part 1: Cream
- **DRUG:** Part 1: Lotion
- **DRUG:** Part 1: Spray 1
- **DRUG:** Part 1: Spray 2
- **DRUG:** Part 2: Lotion
- **DRUG:** Part 2: Aerosol Spray
- **DRUG:** Part 2: Nonaerosol Spray
- **DRUG:** Part 2: Pump Spray

## Key facts

- **NCT ID:** NCT03582215
- **Lead sponsor:** Food and Drug Administration (FDA)
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-18
- **Primary completion:** 2019-02-18
- **Final completion:** 2019-02-18
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03582215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03582215, "Assessment of the Human Systemic Absorption of Sunscreen Ingredients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03582215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*